top of page

New Trial Shows Effectiveness of BPaL Regimen for Highly Drug-Resistant TB

TB Alliance’s ZeNix trial in South Africa and Eastern Europe sought to optimize the 6-month treatment regimen with reduced exposure to the drug linezolid. Read Here.

21 views0 comments

Recent Posts

See All

John Green, the author of several books and a longtime supporter of Partners in Health, discusses his time visiting Sierra Leone’s Lakka Government Hospital, a tuberculosis treatment center. He talks

bottom of page